openPR Logo
Press release

Macular Degeneration Treatment Market Size to Reach US$ 8.6 Bn by 2032, Rising Prevalence of Age-Related Macular Degeneration to Drive Growth

06-30-2023 10:22 PM CET | Health & Medicine

Press release from: Persistence Market Research

Macular Degeneration Treatment Market Size to Reach US$ 8.6 Bn

Macular degeneration, also known as age-related macular degeneration (AMD), is a progressive eye disease that affects the central part of the retina, leading to blurred or loss of vision. The macular degeneration treatment market encompasses various therapeutic approaches, including drug therapies, surgical interventions, and supportive devices, aimed at managing and improving vision in patients with macular degeneration. This article provides a comprehensive analysis of the macular degeneration treatment market, including its overview, market size and growth, market segmentation, regional analysis, market drivers and challenges, market trends, future outlook, key market study points, competitive landscape, and recent developments.

Need More Insights on Competitor Analysis of the Macular Degeneration Treatment Market, Request for Sample@ https://www.persistencemarketresearch.com/samples/33174

Market Overview:

The macular degeneration treatment market involves the development, manufacturing, and distribution of therapeutic products and services aimed at managing macular degeneration. These include pharmaceutical drugs, surgical procedures, and supportive devices such as intraocular lenses, implants, and vision aids. The market focuses on improving visual function, slowing disease progression, and enhancing the quality of life for individuals affected by macular degeneration.

Market Size and Growth:

The global macular degeneration treatment market recorded a CAGR of 6.2% in the last 9 years from 2012 to 2021 and reached a market value of around US$ 8.6 Bn in 2021. The market is estimated to surge ahead at a CAGR of 7.4% to reach US$ 18.8 Bn by the end of 2032.

As assessed by Persistence Market Research, anti-vascular endothelial growth factors accounted for a market share of 60.8% in 2021. Overall, macular degeneration treatment accounts for approximately 18.7% revenue share of the global neurodegenerative disorders treatment market, which was valued at around US$ 45.9 Bn at the end of 2021.

Companies Covered in This Report: F. Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Pfizer Inc., Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Amgen Inc., Biogen, Samsung, Bioepis, Santen Pharmaceutical Co., Ltd.

If You Want To Know the Business Opportunity/Market Value, Purchase the Premium Insight @ https://www.persistencemarketresearch.com/checkout/33174

Market Segmentation: The Macular Degeneration Treatment market can be segmented based on various factors:

By Service Type: The market can be categorized into pharmaceuticals, surgical interventions, and supportive devices. Pharmaceutical treatments include anti-vascular endothelial growth factor (anti-VEGF) drugs, antioxidants, and other medications. Surgical interventions encompass procedures such as laser therapy and photodynamic therapy. Supportive devices include intraocular lenses, implants, and vision aids.
By Sourcing Type: The market can be divided into in-house development and outsourcing of treatment modalities. In-house development refers to the research, development, and manufacturing of treatment options by pharmaceutical companies, medical device manufacturers, and healthcare institutions. Outsourcing involves collaborations, licensing, or partnerships with specialized companies to access advanced treatment solutions.
By Application: The market can be segmented based on the stage and type of macular degeneration, including dry macular degeneration and wet macular degeneration.
By Industry Vertical: The market can be categorized by the industry sectors involved in the development, manufacturing, and distribution of macular degeneration treatment options, such as pharmaceuticals, medical devices, hospitals and clinics, and research institutions.
By Region: The market can be analyzed across regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Market Drivers and Challenges:

The macular degeneration treatment market is driven by several factors. These include the growing prevalence of macular degeneration, the increasing aging population, and the rising demand for effective vision-saving treatments. Technological advancements in drug therapies and surgical interventions, along with the availability of supportive devices, contribute to market growth. However, challenges such as the high cost of treatment, limited accessibility to advanced therapies in developing regions, and the need for early diagnosis and regular monitoring pose obstacles to market expansion. Additionally, the COVID-19 pandemic has impacted the market, with disruptions in healthcare services and delayed elective procedures affecting market growth.

If you want to Purchase Specific Insights by Segment/Region/Competitor, Request For Customization @ https://www.persistencemarketresearch.com/request-customization/33174

Competitive Landscape and Recent Developments:

The macular degeneration treatment market is highly competitive, with key players focusing on research and development, strategic collaborations, and product launches. Major companies operating in the market include Novartis AG, Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, Bayer AG, Santen Pharmaceutical Co., Ltd., Allergan, Inc., Genentech, Inc., Ophthotech Corporation, Acucela Inc., and Alimera Sciences, Inc. These companies strive to develop novel therapies, improve treatment outcomes, and expand their market presence.

Recent developments in the market include the launch of new anti-VEGF drugs with improved efficacy and longer treatment intervals. Furthermore, the exploration of gene therapy and stem cell-based treatments for macular degeneration holds promise for future advancements. The integration of AI and telemedicine solutions for remote monitoring and diagnosis is also a significant development in the market. Collaborations between pharmaceutical companies and research institutions are prevalent to accelerate drug discovery and development processes.

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Macular Degeneration Treatment Market Size to Reach US$ 8.6 Bn by 2032, Rising Prevalence of Age-Related Macular Degeneration to Drive Growth here

News-ID: 3109449 • Views:

More Releases from Persistence Market Research

Fruit Ingredients Market to Reach US$ 111.3 Bn by 2032, Driven by Rising Health Trends
Fruit Ingredients Market to Reach US$ 111.3 Bn by 2032, Driven by Rising Health …
Overview of the Global Fruit Ingredients Market The global fruit ingredients market is witnessing significant growth, driven by rising consumer demand for natural, clean-label, and nutrient-rich food products. In 2025, the market is likely to be valued at US$ 75.0 billion and is expected to reach US$ 111.3 billion by 2032, registering a robust CAGR of 5.8% during the forecast period. Fruit ingredients, which include fruit concentrates, purees, powders, and extracts,
Vegan Dessert Market to Reach US$ 11.9 Bn by 2032, Driven by Rising Health & Plant-Based Demand
Vegan Dessert Market to Reach US$ 11.9 Bn by 2032, Driven by Rising Health & Pla …
Overview of the Market The global vegan dessert market is poised for significant expansion, with an estimated valuation of US$ 5.2 billion in 2025, projected to reach US$ 11.9 billion by 2032. This robust growth reflects a compound annual growth rate (CAGR) of 11.7% during the forecast period from 2025 to 2032. Increasing consumer awareness about health, environmental sustainability, and ethical food consumption is driving the widespread adoption of vegan dessert
Instant Beverage Premix Market to Reach US$148.3 Bn by 2032 Driven by Convenience & Demand
Instant Beverage Premix Market to Reach US$148.3 Bn by 2032 Driven by Convenienc …
Overview of the Global Instant Beverage Premix Market The global instant beverage premix market has witnessed remarkable growth over the past decade, driven by evolving consumer lifestyles and increasing demand for convenient, ready-to-consume beverages. Instant beverage premixes, encompassing products such as instant coffee, tea, flavored drinks, protein powders, and nutritional supplements, cater to busy consumers seeking quick preparation without compromising on taste or nutritional value. These premixes have gained popularity across
Dermacosmetics Market to Reach US$ 87.3 Bn by 2032 at 7.4% CAGR: Persistence Market Research
Dermacosmetics Market to Reach US$ 87.3 Bn by 2032 at 7.4% CAGR: Persistence Mar …
The global dermacosmetics market, estimated at US$ 53 billion in 2025, is forecasted to witness a steady upward trajectory, expanding at a Compound Annual Growth Rate (CAGR) of 7.4% to reach US$ 87.3 billion by 2032. This surge is driven by a confluence of factors ranging from increasing consumer awareness and the rising incidence of skin conditions to a growing preference for advanced, dermatologist-backed skincare solutions. Dermacosmetics, a category that

All 5 Releases


More Releases for Macular

2025-2034 Macular Edema and Macular Degeneration Market Roadmap: Insights for Co …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts How Large Will the Macular Edema and Macular Degeneration Market Size By 2025? In the past few years, the market size for macular edema and macular degeneration has seen significant growth. It is projected to increase from $9.65 billion in 2024 to $10.43 billion in 2025, exhibiting a compound
Macular Edema and Macular Degeneration Market Poised for 7.1% Growth, Set to Hit …
How Are the key drivers contributing to the expansion of the macular edema and macular degeneration market? The growth of the macular edema and macular degeneration market is predicted to be driven by the escalating number of individuals suffering from diabetes. Diabetes is a long-term health condition that results in elevated levels of glucose in the bloodstream. The condition harms the eye's blood vessels, potentially leading to macular edema and macular
Macular Edema and Macular Degeneration Market Outlook 2025-2034: Key Trends, Gro …
"How Big Is the Macular Edema and Macular Degeneration Market Expected to Be, and What Will Its Growth Rate Be? The macular edema and macular degeneration market has seen significant growth in recent years. It will expand from $9.65 billion in 2024 to $10.43 billion in 2025, with a CAGR of 8.1%. Factors contributing to this growth include the aging population, increasing diabetes prevalence, early diagnosis and awareness, global initiatives in
Macular Edema and Macular Degeneration Market to Reach $22.51 Billion by 2034
The global macular edema and macular degeneration market, valued at $10.33 billion in 2023, is on track to grow at a remarkable compound annual growth rate (CAGR) of 7.34%, reaching $22.51 billion by 2034. This substantial market expansion is being fueled by rising treatment innovations, an increasing global prevalence of related diseases, and a surge in technological advancements in diagnostics and therapies. Download White Paper: https://www.towardshealthcare.com/download-statistics/5375 Market Overview and Key Drivers The macular
Macular Edema and Macular Degeneration Market Size, Trends, Growth, Outlook 2024 …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Macular Edema and Macular Degeneration Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $12.84
Macular Edema and Macular Degeneration Market: Key Trends, Competitor Analysis, …
"Exploring the Global Macular Edema and Macular Degeneration Market: A Comprehensive Overview Insights into Macular Edema and Macular Degeneration Market: Global Trends and Analysis Macular Edema and Macular Degeneration Industry - Key Market Dynamics and Trends The macular edema and macular degeneration market size has grown strongly in recent years. It will grow from $8.84 billion in 2023 to $9.65 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The